Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.
Clinical trial NCT01972217 · COMPLETED
Trial details
- NCT number
- NCT01972217
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2017-09-22
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.